MPM BIOIMPACT LLC
CIK 1687078
13F filing for Q2 2026・No. 1,883
- Holdings
- US$1.64B
- Quarter change
- +US$345.05M
- Entries
- 37
- Net bought (estimate)
- −US$45.41M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 7
- Sold out 11
- Cut 22
- Added 7
- Corporate actions 0
- Unchanged 1
Largest holdings
37 stocks worth US$1.64B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| Cullinan Therapeutics, Inc.230031106 | Added | 9,731,341 | US$177.21M | 10.81% |
| AKTSAktis Oncology, Inc.01021M104 | Unchanged | 4,835,872 | US$155.86M | 9.50% |
| Liquidia Corporation53635D202 | Cut | 1,386,174 | US$110.52M | 6.74% |
| RVMDRevolution Medicines, Inc.76155X100 | Cut | 492,483 | US$92.23M | 5.62% |
| CORTCorcept Therapeutics, Inc.218352102 | Cut | 771,028 | US$67.04M | 4.09% |
| Edgewise Therapeutics Inc28036F105 | Cut | 1,620,780 | US$65.85M | 4.02% |
| Travere Therapeutics Inc89422G107 | Cut | 1,122,731 | US$63.78M | 3.89% |
| DBVTDBV Technologies S A23306J309 | Cut | 3,666,284 | US$60.13M | 3.67% |
| Trevi Therapeutics Inc89532M101 | Cut | 3,073,577 | US$57.32M | 3.50% |
| Alumis Inc022307102 | Cut | 2,019,020 | US$56.82M | 3.46% |
Sign in (free) to see its 37 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.